Skip to main navigation
  • Careers
  • Contact Us
Xen 01
  • About Us
    • Management
    • Partnering
    • Board of Directors
  • Pipeline
    • obexelimab (XmAb5871)
    • XmAb7195
    • XmAb13676
    • XmAb14045
    • XmAb18087
  • Technology
    • Bispecific Fc Domains
    • Cytotoxic Fc Domains
    • Immune Inhibitor Fc Domains
    • Xtend Fc Domains
    • Publications
  • Clinical Trials
    • Expanded Access Policy
  • Investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
    • Analyst Coverage
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Investor FAQs
    • Contact Us
    • Email Alerts

You are here:
Home / Investors / Financials & Filings

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
    • SEC Filings
  • Analyst Coverage
  • Stock Information
  • Investor FAQs
  • Contact Us
  • Email Alerts

Tools

Shareholder Tools

  • Snaphot
  • Print
  • Share
  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS

Financials & Filings

Latest Quarterly Financial Results

Show all
2018
Q2
  • Q2 2018 Xencor, Inc. Earnings Conference Call
  • Xencor Reports Second Quarter 2018 Financial Results
  • Form 10-Q

Proxy Statements

Filing date View
Apr 27, 2018 View HTML
0001558370-18-003416.pdf
0001558370-18-003416.xls
May 01, 2017 View HTML
0001558370-17-003113.pdf
0001558370-17-003113.xls

Form 10-K

Filing date View
Feb 28, 2018 View HTML
0001558370-18-001202.pdf
0001558370-18-001202.xls
EX-101.INS - EX-101.INS
Mar 01, 2017 View HTML
0001558370-17-001196.pdf
0001558370-17-001196.xls
EX-101.INS - EX-101.INS

Form 10-Q

Filing date View
Nov 05, 2018 View HTML
0001558370-18-008506.pdf
0001558370-18-008506.xls
EX-101.INS - EX-101.INS
Aug 07, 2018 View HTML
0001558370-18-006482.pdf
0001558370-18-006482.xls
EX-101.INS - EX-101.INS

Copyright Morningstar

Xencor © Copyright 2019
Scroll to top